Matches in Wikidata for { <http://www.wikidata.org/entity/Q57481717> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q57481717 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q57481717 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57481717 description "scientific article published on 09 October 2018" @default.
- Q57481717 description "wetenschappelijk artikel" @default.
- Q57481717 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q57481717 name "Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment" @default.
- Q57481717 name "Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment" @default.
- Q57481717 type Item @default.
- Q57481717 label "Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment" @default.
- Q57481717 label "Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment" @default.
- Q57481717 prefLabel "Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment" @default.
- Q57481717 prefLabel "Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment" @default.
- Q57481717 P1433 Q57481717-85B3D824-8429-454B-A7A4-44DD04CBFD3A @default.
- Q57481717 P1476 Q57481717-60C9901C-36B9-46FF-92CE-5DDD5E19E327 @default.
- Q57481717 P2093 Q57481717-02059037-0352-4F65-A1C9-FCD60DBBEDFD @default.
- Q57481717 P2093 Q57481717-1656D26B-AC39-4B01-B1D0-6E0BC7200826 @default.
- Q57481717 P2093 Q57481717-58CF0410-2B94-455D-9DD0-EBD93F5266C3 @default.
- Q57481717 P2093 Q57481717-B6F548FD-E972-4E62-B010-F2F8BFE89AA5 @default.
- Q57481717 P304 Q57481717-31F1E47D-3CBD-4568-8859-6C95E1693C32 @default.
- Q57481717 P31 Q57481717-769DC6A0-3F56-49BF-8287-B206CE9190B0 @default.
- Q57481717 P356 Q57481717-E7FB1A29-32E4-4498-BAF1-49AAEE676B1B @default.
- Q57481717 P407 Q57481717-36A6E5BD-34B4-4D25-B55E-2F9E01C4EB8C @default.
- Q57481717 P478 Q57481717-0BC04005-4621-4E54-A701-C92F8465D4DA @default.
- Q57481717 P577 Q57481717-440CF297-CAF9-45D7-81D1-C55074D75A00 @default.
- Q57481717 P698 Q57481717-65D1581B-73CF-4B81-AD8C-DF6817DF53FE @default.
- Q57481717 P921 Q57481717-24E0482F-6FBF-4487-A65E-282DF8AC0851 @default.
- Q57481717 P921 Q57481717-ED9C76EB-12BF-4739-826E-F180269F7528 @default.
- Q57481717 P356 J.JOCN.2018.09.027 @default.
- Q57481717 P698 30309801 @default.
- Q57481717 P1433 Q6294963 @default.
- Q57481717 P1476 "Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment" @default.
- Q57481717 P2093 "Dawn Meyer" @default.
- Q57481717 P2093 "Frank Chu" @default.
- Q57481717 P2093 "Katrina Derry" @default.
- Q57481717 P2093 "Lovella Hailey" @default.
- Q57481717 P304 "355-357" @default.
- Q57481717 P31 Q13442814 @default.
- Q57481717 P356 "10.1016/J.JOCN.2018.09.027" @default.
- Q57481717 P407 Q1860 @default.
- Q57481717 P478 "59" @default.
- Q57481717 P577 "2018-10-09T00:00:00Z" @default.
- Q57481717 P698 "30309801" @default.
- Q57481717 P921 Q1931577 @default.
- Q57481717 P921 Q419345 @default.